Research outputs
2025
Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies.
Boardman, S. A., Hetherington, C., Hughes, T., Cook, C., Galea, I., Hilton, O., . . . Michael, B. D. (2025). Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies.. The Journal of infectious diseases, jiaf455. doi:10.1093/infdis/jiaf455
Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.
Wood, G. K., Sargent, B. F., Ahmad, Z. -U. -A., Tharmaratnam, K., Dunai, C., Egbe, F. N., . . . Leek, E. C. (2024). Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.. Nature medicine. doi:10.1038/s41591-024-03309-8
2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain
Dunai, C., Hetherington, C., Boardman, S. A., Clark, J. J., Sharma, P., Subramaniam, K., . . . Michael, B. D. (2024). Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain. Frontiers in Immunology, 15. doi:10.3389/fimmu.2024.1440324
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael, B. D., Dunai, C., Needham, E. J., Tharmaratnam, K., Williams, R., Huang, Y., . . . Menon, D. K. (2024). Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.. Nature communications, 15(1), 2918. doi:10.1038/s41467-024-47320-6
2023
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael, B. D., Dunai, C., Needham, E. J., Tharmaratnam, K., Williams, R., Huang, Y., . . . Menon, D. K. (2023). Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.. Nature communications, 14(1), 8487. doi:10.1038/s41467-023-42320-4
2022
Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts
Wood, G. K., Babar, R., Ellul, M. A., Thomas, R. H., Van Den Tooren, H., Easton, A., . . . Michael, B. D. (2022). Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts. BMJ Neurology Open, 4(2), e000323. doi:10.1136/bmjno-2022-000323
Acute seizure risk in encephalitis; analysis and modelling of 436 patients from two independent multi-centre cohorts (S38.008)
Wood, G., Ellul, M., Thomas, R., Easton, A., Burnside, G., Dunai, C., . . . Michael, B. (2022). Acute seizure risk in encephalitis; analysis and modelling of 436 patients from two independent multi-centre cohorts (S38.008). Neurology, 98(18_supplement). doi:10.1212/wnl.98.18_supplement.2600
Acute seizure risk in encephalitis; analysis and modelling of 436 patients from two independent multi-centre cohorts
Wood, G., Ellul, M., Thomas, R., Easton, A., Burnside, G., Dunai, C., . . . Michael, B. (2022). Acute seizure risk in encephalitis; analysis and modelling of 436 patients from two independent multi-centre cohorts. In NEUROLOGY Vol. 98. Retrieved from https://www.webofscience.com/